General
Preferred name
RIFALAZIL
Synonyms
KRM-1648 ()
ABI-1648 ()
P&D ID
PD039121
CAS
129791-92-0
Tags
drug candidate
natural product
available
Drug Status
investigational
Max Phase
Phase 3
Drug indication
Antibacterial (antimycobacterial)
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
3
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
18
Properties
(calculated by RDKit )
Molecular Weight
940.45
Hydrogen Bond Acceptors
16
Hydrogen Bond Donors
5
Rotatable Bonds
5
Ring Count
7
Aromatic Ring Count
2
cLogP
6.43
TPSA
230.66
Fraction CSP3
0.51
Chiral centers
9.0
Largest ring
24.0
QED
0.08
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Anti-infection
Cell Cycle/DNA Damage
Target
Bacterial
DNA/RNA Synthesis
Source data
